| MODERNA INC. DL-,0001 |
| USA |
| Gesundheit |
| US60770K1079 / A2N9D9 |
| 0QF (Frankfurt) / MRNA (NASDAQ) |
| FRA:0QF, ETR:0QF, 0QF:GR, NASDAQ:MRNA |
| S&P500 |
| https://www.modernatx.com.. |
|
Moderna Inc. is a biotechnology company focused on developing medicines and vaccines based on messenger RNA (mRNA) technology. Its commercial portfolio includes respiratory and infectious disease vaccines, while its broader pipeline spans oncology, r..
>Volltext.. |
| 69701.73 Mio. EUR |
| 66334.17 Mio. EUR |
| 1955.86 Mio. EUR |
| -2702.92 Mio. EUR |
| -2766.12 Mio. EUR |
| -7.01 EUR |
| 1129.8 Mio. EUR |
| 1512.54 Mio. EUR |
| -941.94 Mio. EUR |
| 2.03 |
| -25.34% |
| -11.96% |
| - |
| - |
| - |
| 3 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 14.834.872 Euro. |
| MODERNA |
| 29.09.26 |
|
||||
|
||||
|
||||
|
||||
|